Neuren Pharmaceuticals Limited
15 clinical trials · Sponsor
◉ Watch Neuren Pharmaceuticals Limited
| Record | Firm | Date |
|---|---|---|
| An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome (NCT07593391) | Neuren Pharmaceuticals Limited | 2026-06-08 |
| A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome (NCT07281079) | Neuren Pharmaceuticals Limited | 2025-11-12 |
| An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001) (NCT05879614) | Neuren Pharmaceuticals Limited | 2023-09-01 |
| An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001) (NCT05025332) | Neuren Pharmaceuticals Limited | 2022-10-14 |
| An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001) (NCT05025241) | Neuren Pharmaceuticals Limited | 2022-08-08 |
| An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome (NCT05011851) | Neuren Pharmaceuticals Limited | 2022-07-12 |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy Volunteers (NCT04379869) | Neuren Pharmaceuticals Limited | 2020-05-29 |
Track Neuren Pharmaceuticals Limited automatically
Every clearance here is in the API, with alerts when new ones post.